Bristol Myers Squibb, bluebird bio’s multiple myeloma CAR-T ide-cel scores FDA nod

Bristol Myers Squibb, bluebird bio’s multiple myeloma CAR-T ide-cel scores FDA nod
esagonowsky
Fri, 03/26/2021 – 16:00